Notorious infectious diseases “expert” Anthony Fauci said Wednesday that newborns should begin a series of 3 separate Covid-19 vaccinations starting from the day they turn 6 months old.
“Dose and regimen for children 6 months to 24 months worked well, but it turned out the other group from 24 months to 4 years did not yet reach the level of non-inferiority, so the studies are continued,” Fauci said, referencing effectiveness standard comparison to adults.
“It looks like it will be a three-dose regimen. I don’t think we can predict when we will see it [approved],” he said — adding he can’t speak for the Food and Drug Administration.
“We need to be patient,” he said. “That’s why the system works. The FDA is very scrupulous in their ability and in their effort to make sure that, before something gets approved for any age, and especially with children … that they will be safe, and that they will be effective.”
Many scientists have objected to pumping children with the vaccines at such a young age, often pointing out that current scientific and real-life data demonstrate that children, especially young ones, have virtually no risk of dying from the disease.
The New York Post reported that the White House said Wednesday that “the COVID-19 vaccine regime for kids younger than 4 years old will likely be three doses when it’s approved.”
Also promised was expanded access to millions more of the less widespread Pfizer anti-viral pills in coming months.
“We’ve purchased 20 million treatment courses of the Pfizer pill and we accelerated delivery of the first 10 million from September to the end of June,” said White House coronavirus response coordinator Jeff Zients.
Many have questioned if some of the decisions made by the FDA are at times motivated by factors other than health of the citizen, especially in the wake of recent news of the agency barring the state of Florida from using potentially live-saving monoclonal antibody therapy in order to treat patients affliected with the Wuhan coronavirus. The FDA’s decision to take the treatment away this week is not without precedent — Joe Biden and the HHS had attempted the same in September.
“This evening, without any advanced notice, the US Food and Drug Administration (FDA) revised the Emergency Use Authorization (EUA)…The revised EUAs do not allow providers to administer these treatments within the United States,” the Florida Department of Health wrote in a memo on Monday.